Hold Target Price: Rs 574

Similar documents
Change EPS. (Rs) FY

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

BUY STEEL STRIPS WHEELS LTD. Target Price: Rs Q4FY17: Heavier wheels outperform, strong growth triggers ahead FINANCIAL SUMMARY

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

HOLD. Buyback of Old Mutual s stake in K-Life KOTAK MAHINDRA BANK. Target Price: Rs 965

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

HOLD. Performance remains weak COLGATE-PALMOLIVE INDIA. Target Price: Rs 900

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

HOLD. FY18 off to a good start GODREJ PROPERTIES. Target Price: Rs 486. Q4FY17 key highlights

BUY. Structural changes in the making CAPITAL FIRST. Target Price: Rs 920. Key drivers

BUY. Strong quarter, bright outlook MAHINDRA CIE AUTOMOTIVE. Target Price: Rs 274. Takeaways from concall. Key drivers (%)

HOLD PVR. Operating matrix healthy; footfalls subdued. Target Price: Rs 1,520. Key highlights

BUY Target Price: Rs 1,218

BUY. Quess likely to be spun-off; stay invested THOMAS COOK (INDIA) Target Price: Rs 320

BUY. GST pressures dealt well HINDUSTAN UNILEVER. Target Price: Rs 1,400. Key drivers (%) FY16 FY17 FY18E FY19E

HOLD. Going aggressive in hair oils DABUR INDIA. Target Price: Rs 325. Key drivers (%) FY17 FY18E FY19E

BUY. Q4 hurt by MFI business EQUITAS HOLDINGS. Target Price: Rs 190

BUY. FY17 a blip; gradual recovery ahead APOLLO HOSPITALS ENTERPRISE. Target Price: Rs 1,472

BUY. IIB-BHAFIN merger a done deal INDUSIND BANK. Target Price: Rs 1,920. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

BUY. Well poised for strong growth RBL BANK. Target Price: Rs 650. Key highlights. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

BUY. Shedding non-core assets TATA POWER. Target Price: Rs 136. Financial summary (Consolidated) Key drivers. Price performance

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

NOW ON APP Research at your finger tips

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

BUY. Multiple margin tailwinds; BUY HINDUSTAN UNILEVER. Target Price: Rs 1,010. Key drivers (%) FY16 FY17E FY18E FY19E

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Simplex Infrastructures

Ahluwalia Contracts (India)

Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials

Visaka Industries Ltd

Fineotex Chemical Ltd

BUY. Recovery ahead; upgrade to BUY BAJAJ AUTO. Target Price: Rs 3,905. Key takeaways from our meeting with the management

FY16 FY17 FY18E FY19E

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Near-term pressure, but long-term outlook positive

Cummins India Ltd Bloomberg Code: KKC IN

RELIANCE INDUSTRIES LIMITED

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Nestle India Ltd. RESULT UPDATE

Reliance Housing Finance

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Domestic air passengers increase 16.9% in November

Punjab National Bank

Hindustan Unilever (RHS)

Symphony Ltd. RESULT UPDATE 31st October 2017

Bajaj Finserv (BAFINS) 3130

Arbitrage Opportunity in Wipro buyback

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Bajaj Finserv (BAFINS) 4375

D-Link India (DLILIM) 105

Reliance Capital (RELCAP)

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

ITC Ltd. RESULT UPDATE 27th October, 2017

JSW Steel EDELSTAR FUNDAMENTAL RESEARCH

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Healty cigarette-driven growth

Bajaj Finserv (BAFINS) 5443

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Reliance Capital (RELCAP) 549

BLS International Services

BUY CIPLA INDIA. Steady growth, margin visibility amid headwinds. Target Price: Rs 675. Key drivers

IndusInd Bank (INDBA) 1717

Amber Enterprises India Ltd

Dr Reddy s Laboratories

Initiating Coverage. Uflex Ltd.

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Crompton Greaves Consumer Electricals

Institutional Equities

Singer India (SININ) Focus on tapping small appliances segment. Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Automobiles. Heading Into Strong Earnings Growth Quarter QUARTERLY PREVIEW

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Tata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY. Stock Data. Stock Performance (%) Company Update IT Software India Research

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Key estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,

Jindal Stainless Hisar Ltd.: Q3FY18 Result Update

Lumax Industries (LUMIND)

Colgate-Palmolive India Ltd.

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Overview of Life insurance industry. Date :

Colgate-Palmolive (India)

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Century Plyboards (India)

I Direct. nstinct. September 19, 2017

BUY. Homegrown multinational MOTHERSON SUMI SYSTEMS. Target Price: Rs 525. Meeting highlights. Key drivers

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Mahindra & Mahindra. Source: Company Data; PL Research

Indian Oil Corporation

Larsen & Toubro Ltd.

Transcription:

03 MAY 2017 Quarterly Update Hold Target Price: Rs 574 Q4FY17: Macro overhang persists SQS India BFSI Ltd delivered a modest performance in Q4FY17, with earnings (PAT) coming in at Rs 4.4 Cr, down 58.8% Y-o-Y on account of decline in sales and higher other expenses. In Q4FY17, revenue of the company declined 20.3% Y-o-Y to Rs 57.5 Cr while other expenses increased 23.5% Y-o-Y to Rs 14.2 Cr, resulting in contraction in EBIDTA margin to 13.9% (down 900 bps).the company reported a forex loss of Rs 3.8 Cr in Q4FY17 as against Rs 2.4 Cr loss in Q3FY17 on account of depreciation of GBP and Euro. Company s European region s revenues were up 4.4% Q-o-Q/ down 16.8% Y-o-Y to Rs 32.6 Cr while North American region s revenues were down 12% Q-o-Q/50.5% Y-o-Y to ~Rs 5.5 Cr. Offshore business contributed 41% as against 38% in Q3FY17. 2018 is also likely to be a challenging year for Indian players due to macro overhangs. We revise our earnings estimates downward to Rs 30.2 Cr from previous estimates of Rs 34.9 Cr for FY18E. Reiterate Hold with a revised target price of Rs 574. CMP : Rs 539 Potential Upside : 6.5% MARKET DATA No. of Shares : 1.1 cr FV (Rs) : 10 Market Cap : Rs 604 cr 52-week High / Low : Rs 1240/ Rs 488 Avg. Daily vol. (6mth) : 22285 shares Bloomberg Code : SQSI IN Reuters Code : THIN.BO BSE Code : 533121 NSE Code : SQSBFSI Key Highlights Forex adjusted profit down 32.6% Y-o-Y: In Q4FY17, SQS India reported a forex loss of Rs 3.8 Cr as against a gain of Rs 0.6 Cr in Q4FY16. Adjusting forex loss/gain, adjusted profit of SQS India for Q4FY17 declined 32.6% Y-o-Y to Rs 6.9 Cr. SQS India s 25% revenues were realized in GBP (Great Britain Pound). Depreciation in USD, GBP and Euro against INR was reported at 2%, 15% and 8% respectively which resulted in forex loss for the company. EBIDTA Margin contracted due to higher other expenses and decline in revenue: In Q4FY17, other expenses increased to 24.7% of sales from 23.6% (% of sales)in Q3FY17. Revenue declined 5.5% Q-o-Q/ 20.3% Y-o-Y to Rs 57.5 Cr on account of ramping down of European region s projects. Geographical revenue break- up: In Q4FY17, Europe s contribution in overall revenues of the company has increased to 56.7% v/s 51.3% in Q3FY17 while contribution of Asia in total revenues has come down to 33.8% in Q4FY17 from 38.5% in Q3FY17. Onsite/offshore mix: In Q4FY17, contribution of offshore business increased from 38% in Q3FY17 for 41%. Offshore delivery has higher margins compared to onsite business but revenuesget impacted adversely if a project shifts from onsite to offshore. Client concentration: In Q4FY17, the company had10 clients in USD 0.5-1 mnrevenue,10 clients in USD 1-3 mn revenues and 1 client in more than USD 3 mn revenue bracket. Company s 88% business comes from repeat business. FINANCIAL SUMMARY Y/E March Sales (Rs Cr) PAT (Rs Cr) EPS (Rs) Change FY15 214 21.6 20.5 (28.) 26.3 18.4% 18. 24.0 FY16 264 36.9 35.0 70.5% 15.4 31.3% 30.5% 24.0 FY17E 260 23.1 21.9 (37.5%) 24.6 19.2% 19.3% 20.0 FY18E 295 30.2 28.7 31.1% 18.8 24.9% 24.9% 20.0 Source: Company and Axis Securities P/E (x) RoE PRICE PERFORMANCE 150 RoCE DPS (Rs) 100 50 Akhand Pratap Singh akhand.singh@axissecurities.in 0 May-16 Sep-16 Jan-17 May-17 SQS India BFSI BSE_SENSEX 01

Revenue by Region 1 Revenue Segmental 1 10 8 6 4 31.4% 30.4% 32.7% 36.5% 38.5% 33.8% 16. 15.3% 10.3% 9.7% 10.2% 9.5% 52.6% 54.3% 57. 53.8% 51.3% 56.7% Europe N. America Asia 10 6.9% 7.5% 9.7% 12.3% 14.3% 18.2% 8 33.1% 34.9% 35.5% 33.1% 28. 32.4% 6 7.5% 7.3% 7.5% 7.1% 5.3% 7. 4 52.5% 50.3% 47.3% 47.5% 52.3% 42.4% Q3FY 16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Banking Capital markets & treasury cards & payments Insurance Client Concentration Employee Count 8 1,050 7 6 1,000 1,004 1,002 980 1,002 5 4 950 925 3 1 69. 65. 64. 63. 62. 63. 51. 49. 48. 42. 44. 45. 900 850 874 Top 5 Top 10 800 Employee details Revenue contribution from parent SQS AG Parent SQS AG s contribution in total revenues of SQS India increasing gradually:parents contribution in total revenues of SQS India hasincreased from 4% in FY15 to 19% in Q4FY17. According to SQS India management, contribution from parent in overall revenues can reach to 25% level going forward. 16% 12% 8% 4% 4% 1 1 1 13% 17% 16% 17% 19% FY15 Q1FY16 Q2FY16 Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Source: Company 02

Key Challenges: Currency fluctuation:around 5billing is done in Euro & GBP and depreciation of these currencies against INR can adversely impact the earnings of SQS India. Brexit and US president s policies to adversely impact Indian players. Quarterly Update (Rs. Cr) Q4FY17 Q4FY16 Y-o-Y % Chg Q3FY17 QoQ % Chg FY17E FY18E Y-o-Y % change Net Sales 57.5 72.2 (20.3%) 61 (5.5%) 259.9 294.7 13.4% Less: Personnel 35.4 44.2 (20.) 39 (9.6%) 159.3 172.0 8. Other expenditure 14.2 11.5 23.5% 14 (1.4%) 59.9 69.6 16.1% Total Expenditure 49.6 55.7 (11.) 54 (7.4%) 219.2 241.5 10.2% EBIDTA 8.0 16.5 (51.6%) 7 7.8% 40.8 53.2 30.4% Less: Depreciation 1.4 0.8 76.3% 2 (6.) 5.2 7.1 36.9% Less: Interest 0.1 0.1 0. 0 NM 0.2 0.1 (50.) Add: Other income 0.1 0.2 (50.) 0 0. 0.7 1.2 71.4% Profit Before Extra-ordinary items and Tax 6.6 15.8 (58.4%) 6 9.5% 36.1 47.2 30.7% Less: Total Tax 2.2 5.2 (57.7%) 2 0. 13.0 16.9 30.1% Profit After Tax 4.4 10.6 (58.8%) 3.8 15. 23.1 30.2 31.1% Source: Company, Axis Securities Ltd NM: Not Meaningful 03

Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com. 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, AkhandPratap Singh, MBA (Finance), author/s and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We (Research Analyst) also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-month period. Any holding in stock No 5. ASL has not received any compensation from the subject company in the past twelve months. ASL has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report. Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report. 04

DEFINION OF RATINGS Disclaimer: Ratings Expected absolute returns over 12 months BUY More than 1 HOLD Between 1 and -1 SELL Less than -1 Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. 18002100808/022-61480808, Regd. off.- Axis House, 8th Floor, Wadia International Centre, PandurangBudhkarMarg, Worli, Mumbai 400 025. Compliance Officer: AnandShaha, Email: compliance.officer@axisdirect.in, Tel No: 022-42671582. 05